Idexx Laboratories Shares Rally Following Upbeat Quarterly Results

The company reported a profit of $317.1 million for the quarter, rising from $274.6 million during the same period last year. Earnings reached $4.01 a share, comfortably beating the $3.73 estimate anticipated by analysts. Revenue climbed 10% to $1.21 billion, exceeding the $1.19 billion forecast.

Following these results, management raised its annual earnings outlook to a range of $14.96 to $15.16 a share, up from the previous projection of $14.69 to $14.94. Annual revenue is now expected to hit $4.74 billion to $4.77 billion, topping earlier estimates of $4.7 billion to $4.75 billion. Chief Executive Mike Erickson credited the performance to consistent commercial execution and the company's focus on innovation-driven growth.